United States
Industry
Prestwick Pharmaceuticals has received US FDA orphan drug approval for Xenazine (tetrabenazine). Xenazine will be the first drug available in the US for the treatment of Huntington's...
2008-08-18Companies
As a strategy, outsourcing forms a key part of US-based Eli Lilly's drive to streamline its R&D processes. Over the past few years, the company, like many multinational drugmakers,...
2008-08-08Industry
Gilead Sciences' Viread (tenofovir) and Truvada (emtricitabine) will be tested in single and combination doses in about 16,000 uninfected healthy people for pre-exposure prophylaxis...
2008-08-07Industry
The US FDA has released its list of approved seasonal influenza vaccines for the 2008-2009 season. A total of six vaccines have been approved, which protect against new strains of...
2008-08-07Industry
The US government's 'pilot project' for universal healthcare - the Massachusetts Mandatory Health Insurance Programme - has been dealt a blow in an open letter from more than 250...
2008-08-06Industry
The US FDA has issued a "not-approvable" letter for Schering-Plough's Bridion (sugammadex), a drug used to reverse the effects of anesthesia.
2008-08-04Companies
US-based Vanguard Pharmaceutical has signed a contract to sell the generics portfolio of India's Arbro Pharmaceutical in Latin America and the Caribbean. The deal gives Vanguard exclusive...
2008-08-04Industry
According to the head of the US FDA's Office of Generic Drugs, Gary Buehler, the average time the agency took to evaluate a generic drug application was 19 months in 2007, more than...
2008-08-01
